Ans: D. Contraindicated when platelet count is below 40,000CT-guided bone marrow biopsy is safe in thrombocytopenic patients, with a hemorrhagic complication rate below 1.6% for patients with a platelet count of 20,000-50,000/mL. Routine preprocedure platelet transfusion may not be necessary for patients with a platelet count of 20,000-50,000/mL.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.